14th Jun 2007 09:30
Skyepharma PLC14 June 2007 SKYEPHARMA TO PRESENT AT PIPER JAFFRAY 2nd ANNUAL HEALTH CARE CONFERENCE LONDON, UK, 14 June 2007-- SkyePharma PLC (LSE: SKP) announces today that theCompany's Chief Operating Officer, Dr Ken Cunningham, will make a presentationat the Piper Jaffray 2nd Annual Health Care Conference in London. DrCunningham will deliver his presentation on Thursday 21 June 2007 at 2.40 p.m.Investors may access a live webcast of the presentation at www.skyepharma.comunder the Investor Relations tab. The presentation will be archived for 3months. For further information please contact: SkyePharma PLC Frank Condella +44 20 7491 1777 Ken Cunningham Peter Grant Financial Dynamics (UK Enquiries) David Yates +44 20 7831 3113 Deborah Scott Trout Group (US Enquiries) Christine Labaree +1 617 583 1308 Seth Lewis About SkyePharma PLC Using its proprietary drug delivery technologies, SkyePharma develops newformulations of known molecules to provide a clinical advantage and life-cycleextension. The Company has eleven approved products in the areas of oral,inhalation and topical delivery that are marketed throughout the world byleading pharmaceutical companies. For more information, visit www.skyepharma.com This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
SKP.L